[HTML][HTML] The role of immunological and clinical biomarkers to predict clinical COVID-19 severity and response to therapy—a prospective longitudinal study

A Copaescu, F James, E Mouhtouris, S Vogrin… - Frontiers in …, 2021 - frontiersin.org
Background The association of pro-inflammatory markers such as interleukin-6 (IL-6) and
other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest …

The role of immunological and clinical biomarkers to predict clinical COVID-19 severity and response to therapy-a prospective longitudinal study.

A Copaescu, F James, E Mouhtouris, S Vogrin… - 2021 - cabidigitallibrary.org
Background: The association of pro-inflammatory markers such as interleukin-6 (IL-6) and
other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest …

[HTML][HTML] The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study

A Copaescu, F James, E Mouhtouris… - Frontiers in …, 2021 - ncbi.nlm.nih.gov
Background The association of pro-inflammatory markers such as interleukin-6 (IL-6) and
other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest …

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study

A Copaescu, F James, E Mouhtouris… - Frontiers in …, 2021 - pubmed.ncbi.nlm.nih.gov
Background The association of pro-inflammatory markers such as interleukin-6 (IL-6) and
other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest …

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.

A Copaescu, F James, E Mouhtouris… - Frontiers in …, 2021 - europepmc.org
Background The association of pro-inflammatory markers such as interleukin-6 (IL-6) and
other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest …

[PDF][PDF] The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study

A Copaescu, F James… - … 12: 646095. doi …, 2021 - minerva-access.unimelb.edu.au
Background: The association of pro-inflammatory markers such as interleukin-6 (IL-6) and
other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest …

[PDF][PDF] The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study

A Copaescu, F James, E Mouhtouris… - Front. Immunol. 12 …, 2021 - scienceopen.com
Background: The association of pro-inflammatory markers such as interleukin-6 (IL-6) and
other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest …

[PDF][PDF] The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study

A Copaescu, F James, E Mouhtouris… - Front. Immunol. 12 …, 2021 - researchgate.net
Background: The association of pro-inflammatory markers such as interleukin-6 (IL-6) and
other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest …

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.

A Copaescu, FL James, E Mouhtouris, S Vogrin… - 2021 - ahro.austin.org.au
The association of pro-inflammatory markers such as interleukin-6 (IL-6) and other
biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest …

The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy-A Prospective Longitudinal Study.

A Copaescu, F James, E Mouhtouris… - Frontiers in …, 2021 - europepmc.org
Background The association of pro-inflammatory markers such as interleukin-6 (IL-6) and
other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest …